TVM Capital Healthcare Invests in DEBx Medical to Accelerate Market Introduction of Innovative Wound Care Solution
Key Highlights :
TVM Capital Healthcare, a global specialist healthcare private equity firm, is pleased to announce an investment, from its TVM Healthcare Afiyah Fund, of into DEBx Medical, an -based medical devices company. DEBx Medical has developed a groundbreaking product, DEBRICHEM®, which offers a superior alternative to existing treatments for non-healing chronic wounds. This innovative product is easy to use and highly effective in removing biofilm and curing hard-to-heal wounds.
Chronic wounds pose a significant healthcare challenge, affecting approximately 2.4% of the population throughout their lifetime, and is particularly pronounced in the Gulf Cooperation Council (GCC) countries, where high levels of diabetes contribute to the problem. Hard-to-heal wounds have the potential for poor patient health and quality of life outcomes and represent a substantial cost to healthcare systems. TVM Capital Healthcare's investment in DEBx Medical will enable the company to commence commercialization of its groundbreaking product for the benefit of patients.
As part of the firm's investment, DEBx Medical will establish a regional headquarter and a production base in MENA, thereby accelerating the introduction of its innovative wound care solution to the region. DEBx Medical's product, DEBRICHEM®, has the potential to disrupt the chronic wound care market and help patients to heal fast, safely and effectively.
TVM Capital Healthcare is an emerging markets-focused healthcare private equity firm headquartered in and , with offices in , , , and . The firm invests expansion and growth capital in healthcare companies with a focus on specialized and tech-enabled healthcare services, digital health solutions and platforms, as well as manufacturing companies in pharmaceuticals, medical devices, and diagnostics. Investment and operating partners as well as a strong group of Senior Advisors have long-standing international track records in healthcare and life sciences investing, active board work, contributions to strategy development and implementation, governance and ESG, healthcare M&A, initial public offerings and deep healthcare operations experience.
The firm partners with local Middle Eastern and Southeast Asian management teams to build domestic or regional sector champions and selectively backs companies from or for expansion into the firm's target geographies. TVM Capital Healthcare's investment and operating approach combines strong commercial value creation and returns with responsible investing and a comprehensive ESG framework to build impactful, sustainable and well-governed companies, delivering excellent healthcare services, with continued growth and job creation, in a fair and diverse workplace.
DEBx Medical B.V. is a Dutch medical technology company dedicated to revolutionizing the management of chronic wounds by enabling their healing, thereby improving the outcomes for millions of patients. DEBx Medical aims to support doctors and their patients from diagnosis through treatment, follow-up care and maintenance of a healthy wound bed.
TVM Capital Healthcare's investment in DEBx Medical is set to accelerate the market introduction of a product which will transform the management of chronic wounds, and improve the life of millions of patients. The investment is part of TVM Capital Healthcare's strategy of bringing innovative, best-in-class healthcare solutions to the wider MENA region and will enable DEBx Medical to commence commercialization of its groundbreaking product.
With CE and ISO approvals obtained in , DEBx Medical has already successfully treated over 5,000 patients, and is about to introduce its product to the market. After just one single treatment, more than 90% of chronic wounds start healing. TVM Capital Healthcare's investment is testament to DEBx Medical's technology, and the two companies are looking forward to bringing the product to market together.
TVM Capital Healthcare is a U since 2015, a longstanding member of , a member of a signatory of Ethical Principles in Healthcare ( ) and Investors for Health (I4H), initiatives of the International Finance Corporation of the World Bank (IFC), promoting healthcare growth and ethical principles in healthcare to build transparent and resilient health systems.
With this investment, DEBx Medical is innovating the management of chronic wounds, improving the life of millions of patients – the investment will enable the company to expand its global footprint and build a presence in the MENA region.
